Literature DB >> 24482151

Cholinesterase inhibitors should not be prescribed for mild cognitive impairment.

Tom C Russ1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24482151     DOI： 10.1136/eb-2013-101687

Source DB:  PubMed          Journal:  Evid Based Med        ISSN： 1356-5524


× No keyword cloud information.
  5 in total

Review 1.  A Risk-Benefit Assessment of Dementia Medications: Systematic Review of the Evidence.

Authors:  Jacob S Buckley; Shelley R Salpeter
Journal:  Drugs Aging       Date:  2015-06       Impact factor: 3.923

2.  Developing a Non-Pharmacological Intervention for Individuals With Mild Cognitive Impairment.

Authors:  Juleen Rodakowski; Charles F Reynolds; Oscar L Lopez; Meryl A Butters; Mary Amanda Dew; Elizabeth R Skidmore
Journal:  J Appl Gerontol       Date:  2016-04-22

Review 3.  Non-pharmacological interventions for adults with mild cognitive impairment and early stage dementia: An updated scoping review.

Authors:  Juleen Rodakowski; Ester Saghafi; Meryl A Butters; Elizabeth R Skidmore
Journal:  Mol Aspects Med       Date:  2015-06-10

4.  The Relieving Effects of BrainPower Advanced, a Dietary Supplement, in Older Adults with Subjective Memory Complaints: A Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Jingfen Zhu; Rong Shi; Su Chen; Lihua Dai; Tian Shen; Yi Feng; Pingping Gu; Mina Shariff; Tuong Nguyen; Yeats Ye; Jianyu Rao; Guoqiang Xing
Journal:  Evid Based Complement Alternat Med       Date:  2016-04-11       Impact factor: 2.629

5.  Do nonpharmacological interventions prevent cognitive decline? a systematic review and meta-analysis.

Authors:  Shuqi Yao; Yun Liu; Xiaoyan Zheng; Yu Zhang; Shuai Cui; Chunzhi Tang; Liming Lu; Nenggui Xu
Journal:  Transl Psychiatry       Date:  2020-01-21       Impact factor: 6.222
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.